Biotech Values

[pharmaclown35]

poorgradstudent, you're spot on. i agree. it will be be awhile before they can convince oncologists that the drug in fact was not a fluke. If their technology platform works - then why weren't they advancing neuvenge. they kept on talking about that for awhile, a couple of years ago. and then no announcements on that. they really should in-license something - anything - to diversify away from their current provenge franchise. they just need a back-up plan. or maybe new technology. something.